Total amount raised
Latest funding date
Location
Jay Galeota is the CEO of Kallyope, a biotechnology company focused on gut-brain axis therapeutics. A global healthcare leader and board member with a distinguished career spanning the pharmaceutical and biotechnology industries, he brings extensive executive experience to his role leading Kallyope's research and development efforts.
Who is the CEO of Kallyope?
Jay Galeota is a global healthcare leader with a career defined by executive roles across the pharmaceutical and biotechnology sectors. Before joining Kallyope, he served as President and Chief Executive Officer of Inheris BioPharma, Inc. and previously as President of G&W Laboratories, demonstrating a consistent record of leading healthcare organizations at the highest level. Earlier in his career, he held various sales and marketing leadership roles at Merck, building a strong commercial foundation in the industry.
As President and CEO of Kallyope, Jay Galeota leads the company's mission to pioneer gut-brain axis therapeutics, driving innovative programs aimed at transforming the understanding and treatment of disease through gut biology.
Work History
Jay Galeota's work history reflects broad leadership experience across the pharmaceutical and biotechnology industries. Here is a detailed list of his roles:
Education History
Jay Galeota earned his degree in Biology/Biological Sciences from Villanova University, where he built the scientific foundation that would underpin his long career as a leader in the healthcare and biotechnology industries.
When did Jay Galeota join Kallyope?
Jay Galeota assumed the role of President and Chief Executive Officer at Kallyope in August 2021. Since taking the helm, he has guided the company in advancing its pioneering research into the gut-brain axis and expanding its portfolio of novel therapeutic programs.
